SCHEMBL30126087

SCHEMBL30126087

COc1cc2ncnc(Cl)c2nc1N1CCN(C(=O)OC(C)(C)C)C2(CC2)C1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ JAK3 P52333 3/20 0.43
▸ RET P07949 1/20 0.37
▸ MAP4K4 O95819 2/20 0.36
▸ EPHA2 P29317 2/20 0.36
▸ KDR P35968 2/20 0.36
▸ EPHB4 P54760 2/20 0.36
▸ TLR9 Q9NR96 4/20 0.36
▸ TLR7 Q9NYK1 2/20 0.36
▸ ACHE P22303 1/20 0.36
▸ BACE1 P56817 1/20 0.36
▸ PDGFRB P09619 4/20 0.35
▸ PGK1 P00558 1/20 0.35
▸ PDGFRA P16234 2/20 0.35
▸ ERBB2 P04626 1/20 0.34
▸ CNR1 P21554 1/20 0.34
▸ CNR2 P34972 1/20 0.34
▸ ENPP1 P22413 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30126525 0.90 JAK3 (0.44) JAK3RETMAP4K4EPHA2KDR
SCHEMBL30126746 0.88 JAK3 (0.44) JAK3RETMAP4K4CNR1CNR2
SCHEMBL31257369 0.84 TLR9 (0.49) MAP4K4EPHA2KDREPHB4TLR9
Hydrochloric Acid SCHEMBL31257542 0.83 TLR9 (0.48) MAP4K4EPHA2KDREPHB4TLR9
SCHEMBL30126115 0.81 JAK3 (0.42) JAK3RETMAP4K4CNR1CNR2
SCHEMBL30127598 0.78 JAK3 (0.45) JAK3RETMAP4K4TLR9CNR1
SCHEMBL30126244 0.76 RET (0.44) JAK3RETMAP4K4
SCHEMBL30127295 0.75 EGFR (0.49) KDR
SCHEMBL30127328 0.75 MAP4K4 (0.52) JAK3RETMAP4K4
SCHEMBL31257323 0.73 TLR9 (0.52) MAP4K4EPHA2KDREPHB4TLR9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022266458-A1 6-HETEROCYCLOALKYL-QUINAZOLINE DERIVATIVES AND USES THEREOF BLACK DIAMOND THERAPEUTICS, INC. (US) 2022-12-22 — — WO disclosed
Send feedback